pharmaphorum May 13, 2024
Monitoring of heart failure patients in their homes using a wearable developed by Analog Devices Inc (ADI) has shown in a new study that it may be able to reduce costly hospitalisations.
The research – which has just been presented at the European Society of Cardiology’s Heart Failure Congress in Lisbon – showed that ADI’s Sensinel cardiopulmonary management system was able to detect changes in fluid in patients with heart failure that could be a precursor to readmission to hospital.
The Sensinel system, which was launched in the US earlier this year, consists of a wearable that is applied to the skin of the patient’s chest, communicating via Bluetooth with a mobile app that provides information to patients and healthcare...
Today's Sponsors
Today's Sponsor